Premium Only Content

First Type 1 Diabetes Patient Receiving Novel Gene-Edited Cell Replacement Therapy
Vertex Pharmaceuticals, a biotech based in Boston, is acquiring ViaCyte’s stem-cell derived cell replacement therapies to take the next step of providing a cure for Type 1 diabetes (T1D) to the public. In fact, they’re buying the whole company for 320 million dollars.
Back in February, ViaCyte and partner CRISPR Therapeutics dosed their first patient in a Phase I trial of VCTX210 for T1D. The therapy is an investigational, patient-derived, gene-edited, immune-evasive, stem cell therapy. The therapy combines CRISPR’s gene-editing expertise with ViaCyte’s proprietary pluripotent stem cell line. VCTX210 produces pancreatic cells that won’t be rejected by the patient’s immune system but should differentiate into pancreatic endoderm cells, which will then produce insulin.
-
6:58
Adam Does Movies
17 hours ago $0.05 earnedCaught Stealing - Movie Review
598 -
23:41
JohnXSantos
14 hours agoI Built a $1M Clothing Line for My Toddler in Just 14 Days
4751 -
30:00
Nicholas Bowling
13 hours ago30 Minutes of EXPOSING Religious Hypocrites! (They Literally Run Away)
380 -
LIVE
Joe Donuts Live
3 hours ago🟢 BF2042 Explosive Action: Training for Battlefield 6!
112 watching -
47:29
Man in America
20 hours agoIT DOESN'T ADD UP: The Trans Shooter's Story Is FULL of Holes
77.6K103 -
LIVE
FyrBorne
11 hours ago🔴Warzone M&K Sniping: Through the Fyr And Flames (Of SBMM)
164 watching -
LIVE
Dorian_D
1 day ago🔴 Dorian's First-Time Mega Man Legends 2 Playthrough: Full Gameplay Adventure!
64 watching -
41:08
The Finance Hub
20 hours ago $0.12 earnedBREAKING: MELANIA TRUMP JUST DROPPED A MAJOR BOMBSHELL!!!
4214 -
16:43
RTT: Guns & Gear
1 day ago $0.10 earnedBest Day/Night Vision Scope for The Money? DNT Optics ZULUS HD V2
5381 -
2:12
The Quiet Part
16 hours agoCensored Everywhere Else: What’s Really Happening With MAID
326